Market Tracker

09/26 4:35am ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.66
Delayed Data
As of Sep 23
 -0.02 / -1.19%
Today’s Change
1.23
Today|||52-Week Range
2.31
-14.43%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.68
Today’s open1.65
Day’s range1.65 - 1.70
Volume76,643
Average volume (3 months)45,344
Market cap$64.1M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
MBRXMoleculin Biotech In...-0.25-4.19%
SNSSSunesis Pharmaceutic...-0.08-1.77%
CRMECardiome Pharma Corp0.000.00%
XOMAXOMA Corp-0.00-0.02%
Data as of 09/23/2016

Financials

Next reporting dateNovember 4, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts